Citations

Clear

1432 citation(s) found for "Uk, Nathan".

Pre-Transplant Biomarkers of Cellular Senescence Are Associated with Death with Function After Kidney Transplantation
Lorenz, Elizabeth C. , Bentall, Andrew , Smith, Byron H. , Park, Walter D. , Hickson, LaTonya J. , Rule, Andrew D. , LeBrasseur, Nathan K. , Stegall, Mark D.

Mayo Clinic

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 342-343

10.1681/asn.20233411s1342d Get It

12-Month Analysis of ILLUMINATE-A, a Phase 3 Study of Lumasiran: Sustained Oxalate Lowering and Kidney Stone Event Rates in Primary Hyperoxaluria Type 1
Saland, Jeffrey M. , Groothoff, Jaap W. , Frishberg, Yaacov, Hulton, Sally A., Koren, Michael J. , Overcash, Jeffrey S., Sellier-Leclerc, Anne-Laure A., Shasha‐Lavsky, Hadas , Magen, Daniella , Moochhala, Shabbir H. , Šimková, Eva, Sas, David J. , Meliambro, Kristin, Ngo, Taylor , Fujita, Kenji P. , Gansner, John M. , McGregor, Tracy L., Sellier‐Leclerc, Anne‐Laure , Deschênes, Georges , Hayes, Wesley Nathan , Fuster, Daniel Guido , Coenen, Martin , Garrelfs, Sander F. , Lieske, John C.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: B8-B8

10.1681/asn.20203110s1b8c Get It

ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1)
Michael, Mini , Cochat, Pierre , Magen, Daniella , Hoff, William van’t , Sas, David J. , Schalk, Gesa, Shasha‐Lavsky, Hadas , Bae, Kyounghwa, Seddighzadeh, Ali, Garg, Pushkal, Vaishnaw, Akshay, McGregor, Tracy L., Fujita, Kenji P. , Frishberg, Yaacov, Deschênes, Georges , Hayes, Wesley Nathan

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 515-515

10.1681/asn.20203110s1515a Get It

Quantifying Murine Total Kidney Volume with Robotic 3D Ultrasound
Beaumont, Nathan , Holmes, Heather L. , Gessner, Ryan C., Kline, Timothy L. , Czernuszewicz, Tomasz J. , Rojas, Juan D. , Dayton, Paul A. , Romero, Michael F.

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 498-498

10.1681/asn.20203110s1498b Get It

Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair
Saul, Dominik , Doolittle, Madison L. , Froemming, Mitchell N. , Kosinsky, Robyn Laura , Vos, Stephanie J. B. , Ruan, Ming, LeBrasseur, Nathan K. , Chandra, Abhishek , Pignolo, Robert J. , Rowsey, Jennifer L. , Kosinsky, Robyn L, Vos, Stephanie J, LeBrasseur, Nathan K , Kosinsky, Robyn Laura , Saul, Dominik , Chandra, Abhishek , Vos, Stephanie J., Passos, João F. , Farr, Joshua N. , Monroe, David G. , Khosla, Sundeep

Mayo Clinic

Journal of Clinical Investigation | May 16, 2024 | Volume: 134 | Issue: 12 | Pages: No page available

10.1172/jci179834 | PMID 38753433 Get It

Cells expressing features of senescence, including upregulation of p21 and p16, appear transiently following tissue injury, yet the properties of these cells or how they contrast with age-induced senescent cells remains unclear. Here, we used skeletal injury as a model and identified the rapid appearance following fracture of p21 + cells expressing senescence markers, mainly as osteochondroprogenitors (OCHs) and neutrophils. Targeted genetic clearance of p21 + cells suppressed senescence-associated signatures within the fracture callus and accelerated fracture healing. By contrast, p21 + cell clearance did not alter bone loss due to aging; conversely, p16 + cell clearance, known to alleviate skeletal aging, did not affect fracture healing. Following fracture, p21 + neutrophils were enriched in signaling pathways known to induce paracrine stromal senescence, while p21 + OCHs were highly enriched in senescence-associated secretory phenotype factors known to impair bone formation. Further analysis revealed an injury-specific stem cell–like OCH subset that was p21 + and highly inflammatory, with a similar inflammatory mesenchymal population (fibro-adipogenic progenitors) evident following muscle injury. Thus, intercommunicating senescent-like neutrophils and mesenchymal progenitor cells were key regulators of tissue repair in bone and potentially across tissues. Moreover, our findings established contextual roles of p21 + versus p16 + senescent/senescent-like cells that may be leveraged for therapeutic opportunities.
Vocal cord nodules caused by Mycobacterium avium infection
Chiu, C -Y, Yi, Eunhee S. , Chiu, C -Y, Bayan, Semirra L. , Cummins, Nathan W.

Mayo Clinic

QJM: An International Journal of Medicine | May 2, 2024 | Volume: 117 | Issue: 9 | Pages: 667-668

10.1093/qjmed/hcae091 | PMID 38696764 Get It

Extracorporeal-CPR Versus Conventional-CPR for Adult Patients in Out of Hospital Cardiac Arrest- Systematic Review and Meta-analysis
Hostetter, Logan , Finch, Alex, Gerberi, D., Reddy, S., Garcia, Santiago A. , Bellolio, Fernanda , Smischney, Nathan J.

Mayo Clinic

C45. CARDIAC CRITICAL CARE: AT THE HEART OF THE MATTER | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5707-A5707

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5707 Get It

High Airway TSLP Levels in Asthma Associate With More Severe Disease and Multiple Biomarkers of Type 2 Inflammation
Khanna, Kritika , Tang, M., Jackson, Nathan D. , Charbit, Annabelle R. , Bleecker, Eugene R. , Comhair, S.A.A., Denlinger, Loren C. , Erzurum, Serpil C. , Hastie, Annette T. , Moore, W.C., Israel, Elliot , Jarjour, N.N., Mauger, David T. , Phillips, Brenda R. , Woodruff, Prescott G. , Fahy, J.V., Castro, Mario , Levy, Bruce David , Johansson, Mats W. , Sumino, Kaharu , Wenzel, Sally E. , Seibold, Max A.

Mayo Clinic

B16. NOVEL INSIGHTS INTO ASTHMA PATHOGENESIS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A3014-A3014

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3014 Get It

Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients
Aksamit, Timothy R. , Locantore, Nicholas , Ali, Juzar , Behrman, Megan, Brunton, Amanda E. , Chalmers, Sarah , Choate, Radmila , Dean, Nathan C. , DiMango, Angela, Fraulino, David , Johnson, Margaret M. , Lapinel, N. , McShane, Pamela J. , Miller, Bruce E. , Naureckas, Edward T. , O’Donnell, Anne E., Olivier, Kenneth N., Prusinowski, Elly, Richards, C. , Rhyne, Gloria, Thomashow, Byron, Tino, Gregory , Tsui, K., Varghese, Sumith Abraham, Warren, Heather E., Winthrop, Kevin , Zha, Beth Shoshanna, Addrizzo-Harris, Doreen , Basavaraj, Ashwin , Brunton, Amanda E , Chalmers, Sarah , Choate, Radmila , Dean, Nathan C , Johnson, Margaret M , Maselli, Diego J , McShane, Pamela J , Miller, Bruce E , O'Donnell, Anne E , Olivier, Kenneth N , Restrepo, Marcos I , Richards, Christopher J , Solomon, George M , Tal-Singer, Ruth , Zha, Beth Shoshanna , Addrizzo‐Harris, Doreen , BARKER, ALAN ROBERT , Metersky, Mark L. , Schmid, Andreas, Tal‐Singer, Ruth , Varghese, Sumith Abraham

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 26, 2024 | Volume: 210 | Issue: 1 | Pages: 108-118

10.1164/rccm.202307-1165oc | PMID 38668710 Get It

Abstract Rationale Nontuberculous mycobacteria (NTM) are prevalent among patients with bronchiectasis. However, the long-term natural history of patients with NTM and bronchiectasis is not well described. Objectives To assess the impact of NTM on 5-year clinical outcomes and mortality in patients with bronchiectasis. Methods Patients in the Bronchiectasis and NTM Research Registry with ⩾5 years of follow-up were eligible. Data were collected for all-cause mortality, lung function, exacerbations, hospitalizations, and disease severity. Outcomes were compared between patients with and without NTM at baseline. Mortality was assessed using Cox proportional hazards models and the log-rank test. Measurements and Main Results In total, 2,634 patients were included: 1,549 (58.8%) with and 1,085 (41.2%) without NTM at baseline. All-cause mortality (95% confidence interval) at Year 5 was 12.1% (10.5%, 13.7%) overall, 12.6% (10.5%, 14.8%) in patients with NTM, and 11.5% (9.0%, 13.9%) in patients without NTM. Independent predictors of 5-year mortality were baseline FEV1 percent predicted, age, hospitalization within 2 years before baseline, body mass index, and sex (all P < 0.01). The probabilities of acquiring NTM or Pseudomonas aeruginosa were approximately 4% and 3% per year, respectively. Spirometry, exacerbations, and hospitalizations were similar, regardless of NTM status, except that annual exacerbations were lower in patients with NTM (P < 0.05). Conclusions Outcomes, including exacerbations, hospitalizations, rate of loss of lung function, and mortality rate, were similar across 5 years in patients with bronchiectasis with or without NTM.